Loading...

Major Indexes

Financial Summary


Illumina Inc.

Illumina Inc. (ILMN)

$354.7
5.28 (+1.51%)
Buy
A+
Market Info
Financial Info
Financial Modelling
Symbol ILMN
Price 354.7$
Beta 1.04
Volume Avrg. 1.39M
Market Cap 52.14B
Shares (2019) 149,000.00K
Last Div 0
Dividend Yield -
DCF Unlevered 146.85 Strong Sell
DCF Levered 565.74 Strong Buy
ROE 21.72% Buy
ROA 13.70% Buy
Operating Margin 27.80% Strong Buy
Debt / Equity 58.60% Buy
P/E 46.11 Strong Buy
P/B 10.01 Strong Buy

Income Statement

Download ILMN income statement Download ILMN income statement Download ILMN income statement
Year 2019 2018 2017 2016 2014 2013 2012 2011 2010
Earnings Per Share Basic 0.59-1.231.002.613.194.965.636.81
Net Profit Margin 0.11-0.130.090.190.210.260.250.28
Earnings Per Share Diluted 0.53-1.130.902.373.104.925.566.74
Revenue 666.32-1,148.521,421.181,861.362,219.762,752.003,333.003,543.00
Weighted Average Shares Outstanding 125.09-123.00125.08135.55144.83146.00147.00147.00
Gross Profit 453.88-773.53911.891,297.711,549.291,826.002,300.002,467.00
Weighted Average Shares Outstanding (Diluted) 123.15-133.69139.94148.98149.07148.00149.00149.00
Sales, General and Administrative Expense 176.34-285.99381.04466.28524.66674.00794.00835.00
Dividend per Share ---------
Operating Income 125.60-200.75134.11514.71612.84606.00883.00985.00
Gross Margin 0.68-0.670.640.700.700.660.690.70
Earnings before Tax 114.13-222.61-53.70448.76583.141,043.00894.001,118.00
EBITDA Margin 0.25-0.260.190.360.350.290.330.34
Net Income 72.28-151.25125.31353.35461.56726.00826.001,002.00
EBIT Margin 0.21-0.170.090.280.280.220.260.28
Net Income - Discounted ops ---------
Profit Margin 0.11-0.130.090.190.210.260.250.28
Preferred Dividends ---------
Free Cash Flow margin 0.00-0.000.000.000.000.000.000.00
R&D Expenses 140.62-231.03276.74388.06401.53546.00623.00647.00
Interest Expense 23.72-37.7839.6941.7342.1237.0057.0052.00
Earnings Before Tax Margin 0.17-0.19-0.040.240.260.380.270.32
Consolidated Income 72.28-151.25125.31353.35461.56726.00826.001,002.00
EBIT 137.84-200.75134.11514.71612.84606.00883.00985.00
EBITDA 169.03-299.55268.27665.35777.78792.001,103.001,219.00
Income Tax Expense 41.84-71.3534.0195.41125.75365.00112.00128.00
Operating Expenses 328.28-572.78777.78854.34936.451,220.001,417.001,482.00
Cost of Revenue 212.45-374.99509.29563.65670.47926.001,033.001,076.00
Net Income Com 72.28-151.25125.31353.35461.56726.00826.001,002.00
Net Income - Non-Controlling int ---------

Balance Sheet Statement

Download ILMN balance shet statement Download ILMN balance sheet statement Download ILMN balance sheet statement
Year 2019 2018 2017 2016 2014 2013 2012 2011 2010
Total current liabilities 441.24-304.57322.06722.16610.49746.001,804.00665.00
Other Liabilities 98.25--27.2997.14-40.79-101.97132.00148.00695.00
Long-term debt --805.41839.30986.781,015.651,182.00890.001,141.00
Cash and cash equivalents 144.63-433.98711.64636.15768.771,225.001,144.002,042.00
Total debt 290.20-842.37868.591,291.041,090.581,192.001,997.001,141.00
Cash and short-term investments 693.53-1,350.20711.641,338.371,386.222,145.003,512.003,414.00
Deferred revenue ---------
Inventories 92.78-158.72154.10191.14270.78333.00386.00359.00
Tax Liabilities ---------
Goodwill and Intangible Assets 257.24-499.521,054.231,039.401,026.25946.001,016.00969.00
Deposit Liabilities ---------
Tax assets 67.39-40.1888.4849.85-88.0070.0064.00
Total non-current liabilities 124.45-970.231,066.601,195.471,330.671,630.001,249.001,343.00
Total current assets 981.59-1,787.051,617.541,889.602,096.822,980.004,490.004,451.00
Total liabilities 565.69-1,247.501,485.801,876.841,839.192,508.003,201.002,703.00
Payables 52.78-65.7373.6682.63139.23160.00184.00149.00
Other comprehensive income 2.83-1,232.211,322.36900.87823.89492.00674.00539.00
Short-term investments 548.89-916.22-702.22617.45920.002,368.001,372.00
Retained earnings (deficit) -280.23-82.55207.85561.211,022.762,256.003,083.004,067.00
Property, Plant & Equipment Net 117.19-166.17202.67265.26342.69931.001,075.00889.00
Total non-current assets 448.35-779.041,401.471,450.041,590.922,277.002,469.002,865.00
Other Assets 37.54--------
Net Debt -403.32-408.39156.96654.88321.81-33.00853.00-901.00
Investments 548.89-916.22-702.22617.45920.002,368.001,372.00
Total shareholders equity 864.25-1,318.581,533.201,462.801,848.552,749.003,758.004,613.00
Total assets 1,429.94-2,566.093,019.013,339.643,687.755,257.006,959.007,316.00
Long-term investments ---------
Receivables 157.75-214.97238.95289.46385.53411.00514.00573.00
Short-term debt 290.20-36.9729.29304.2674.9310.001,107.00-

Cash Flow Statement

Download ILMN cash flow statement Download ILMN cash flow statement Download ILMN cash flow statement
Year 2019 2018 2017 2016 2014 2013 2012 2011 2010
Insurance (repayment) of debt ---------
Net Cash/Marketcap 0.00--------
Insurance (buybacks) of shares ---------
Depreciation & Amortization 31.18-98.79134.16150.64164.94186.00220.00234.00
Dividend payments ---------
Operating Cash Flow 172.19-291.87386.42501.27659.60875.001,142.001,051.00
Acquisitions and disposals -1.32--83.16-523.50-3.29-36.58--100.00-
Free Cash Flow 116.12-210.86295.86359.06516.35563.00846.00842.00
Net cash flow / Change in cash -182.39-131.00277.66-75.48132.62490.00-81.00898.00
Effect of forex changes on cash 0.85--0.10-0.40-3.38-2.075.00-4.00-1.00
Financing Cash Flow -98.86--10.76-38.72-166.75-418.76-176.00594.00-897.00
Investment purchases and sales -199.17-117.78239.18-86.9519.9070.00-1,603.00682.00
Capital Expenditure -56.07-81.0190.56142.22143.25312.00296.00209.00
Stock-based compensation 21.49-94.32105.83152.55132.59164.00193.00194.00
Investing Cash Flow ---------

Retained Earning Schedule

Year 2019 2018 2017 2016 2014 2013 2012 2011 2010
Retained Earnings (Previous Year) --280-83208-1,0232,2563,083
Net Income 72-1511253534627268261,002
Stock Dividends -353280-69--5615071-18
Dividend Paid ---------
Retained Earnings -280-832085611,0232,2563,0834,067

PPE Schedule

Year 2019 2018 2017 2016 2014 2013 2012 2011 2010
Gross PPE -117-166203-3439311,075
Annual Depreciation 173-11785-54-80199276-152-395
Capital Expenditure -56-8191142143312296209
Net PPE 117-1662032653439311,075889

Intangible and Goodwill Schedule

Year 2019 2018 2017 2016 2014 2013 2012 2011 2010
Intangible and Goodwill (Previous Year) -257-5001,054-1,0269461,016
New Purchases -199-118239-872070-1,603682
Intangible and Goodwill 257-5001,0541,0391,0269461,016969

About


Francis A. DeSouza
Healthcare
Medical Instruments & Equipment
Nasdaq Global Select

Illumina Inc engages in life science tools and machines for analyzing genetic material. The company primarily engages in microarray and genome sequencing machines and disposables. It also provides sequencing services through its products.